Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan pledges US$3 million to Pacific Resilience Facility
09/16/2025 03:22 PM - Sports
Taiwan's Teng shines despite Giants' 8-1 loss to D-Backs
09/16/2025 03:13 PM - Society
Imported melons, cakes blocked at border over pesticide, preservatives
09/16/2025 03:10 PM - Society
President Lai witnesses installation of Danjiang Bridge's final span
09/16/2025 02:55 PM - Politics
Taiwan raises travel alert to Nepal following deadly unrest
09/16/2025 02:23 PM